Dashboard
Manage Tickers

EXAS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

exact-sciences-shares-resume-trade
Exact Sciences Shares Resume Trade
11/19/2025 18:48:29

Core News & Articles
UPDATE: 'Abbott Weighs Takeover of Cancer ...
11/19/2025 18:41:40

https://www.bloomberg.com/news/articles/2025-11-19/abbott-weighs-takeover-of-cancer-test-maker-exact-sciences

exact-sciences-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-1395
Exact Sciences Shares Halted On Circuit Br...
11/19/2025 18:39:22

piper-sandler-maintains-overweight-on-exact-sciences-raises-price-target-to-80
Piper Sandler Maintains Overweight on Exac...
11/11/2025 17:01:37

Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target ...

exact-sciences-announces-expiration-hsr-waiting-period-for-license-to-freenomes-blood-based-colorectal-cancer-screening-tests-co-updates-fy25-adj-ebitda-guidance-to-reflect-initial-75m-cash-payment-sees-adj-ebitda-395m-405m
Exact Sciences Announces Expiration HSR Wa...
11/10/2025 12:10:06

exact-sciences-releases--validation-results-from-its-altus-study-showing-that-the-oncoguard-liver-blood-test-provides-superior-early-stage-and-overall-sensitivity-for-detecting-hepatocellular-carcinoma-compared-to-the-current-standard-of-care
Exact Sciences Releases Validation Result...
11/07/2025 13:06:30

Oncoguard® Liver blood test delivers seven times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus...

wells-fargo-maintains-overweight-on-exact-sciences-raises-price-target-to-85
Wells Fargo Maintains Overweight on Exact ...
11/05/2025 15:19:29

Wells Fargo analyst Brandon Couillard maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target f...

td-cowen-maintains-buy-on-exact-sciences-raises-price-target-to-90
TD Cowen Maintains Buy on Exact Sciences, ...
11/04/2025 18:44:55

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

td-cowen-maintains-buy-on-exact-sciences-raises-price-target-to-90
TD Cowen Maintains Buy on Exact Sciences, ...
11/04/2025 18:44:55

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

palantir-weighs-on-wall-street-bitcoin-slumps-5-whats-moving-markets-tuesday
Palantir Weighs On Wall Street, Bitcoin Sl...
11/04/2025 18:22:32

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, o...

baird-maintains-outperform-on-exact-sciences-raises-price-target-to-88
Baird Maintains Outperform on Exact Scienc...
11/04/2025 17:21:04

Baird analyst Catherine Schulte maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $7...

benchmark-maintains-buy-on-exact-sciences-raises-price-target-to-75
Benchmark Maintains Buy on Exact Sciences,...
11/04/2025 16:14:19

Benchmark analyst Bruce D. Jackson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $60 to...

guggenheim-maintains-buy-on-exact-sciences-raises-price-target-to-75
Guggenheim Maintains Buy on Exact Sciences...
11/04/2025 15:38:14

Guggenheim analyst Subbu Nambi maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $70 to $75.

these-analysts-raise-their-forecasts-on-exact-sciences-following-better-than-expected-q3-results
These Analysts Raise Their Forecasts On Ex...
11/04/2025 14:25:10

barclays-maintains-overweight-on-exact-sciences-raises-price-target-to-77
Barclays Maintains Overweight on Exact Sci...
11/04/2025 14:15:00

Barclays analyst Luke Sergott maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target from $65 ...

amazon-to-rally-around-24-here-are-10-top-analyst-forecasts-for-tuesday
Amazon To Rally Around 24%? Here Are 10 To...
11/04/2025 14:04:30

stifel-maintains-buy-on-exact-sciences-raises-price-target-to-80
Stifel Maintains Buy on Exact Sciences, Ra...
11/04/2025 12:20:21

Stifel analyst Daniel Arias maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $67 to $80.

btig-maintains-buy-on-exact-sciences-raises-price-target-to-85
BTIG Maintains Buy on Exact Sciences, Rais...
11/04/2025 11:56:05

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $75 to $85.

correction-exact-sciences-q3-adj-eps-024-beats-007-estimate-sales-850739m-beat-810178m-estimate
CORRECTION: Exact Sciences Q3 Adj. EPS $0....
11/03/2025 22:46:19

Exact Sciences (NASDAQ:EXAS) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.07...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
11/03/2025 21:12:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION